Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone

Joseph A. Tamasi, Anatoliy Vasilov, Emi Shimizu, Noah Benton, Joshua Johnson, Claudine L. Bitel, Nigel Morrison, Nicola Partridge

Research output: Contribution to journalArticle

Abstract

Parathyroid hormone (PTH) has a significant role as an anabolic hormone in bone when administered by intermittent injection. Previous microarray studies in our laboratory have shown that the most highly regulated gene, monocyte chemoattractant protein-1 (MCP-1), is rapidly and transiently induced when hPTH(1-34) is injected intermittently in rats. Through further in vivo studies, we found that rats treated with hPTH(1-34) showed a significant increase in serum MCP-1 levels 2 hours after PTH injection compared with basal levels. Using immunohistochemistry, increased MCP-1 expression in osteoblasts and osteocytes is evident after PTH treatment. PTH also increased the number of marrow macrophages. MCP-1 knockout mice injected daily with hPTH(1-34) showed less trabecular bone mineral density and bone volume compared with wild-type mice as measured by peripheral quantitative computed tomography (pQCT) and micro-computed tomography (μCT). Histomorphometric analysis revealed that the increase in osteoclast surface and osteoclast number observed with intermittent PTH treatment in the wild-type mice was completely eliminated in the MCP-1 null mice, as well as much lower numbers of macrophages. Consequently, the lack of osteoclast and macrophage activity in the MCP-1 null mice was paralleled by a reduction in bone formation. We conclude that osteoblast and osteocyte MCP-1 expression is an important mediator for the anabolic effects of PTH on bone.

Original languageEnglish (US)
Pages (from-to)1975-1986
Number of pages12
JournalJournal of Bone and Mineral Research
Volume28
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Chemokine CCL2
Parathyroid Hormone
Teriparatide
Bone and Bones
Osteoclasts
Osteocytes
Macrophages
Osteoblasts
Tomography
Anabolic Agents
Injections
Osteogenesis
Knockout Mice
Bone Density
Blood Proteins
Bone Marrow
Immunohistochemistry
Hormones
Therapeutics
Genes

Keywords

  • BONE ANABOLISM
  • BONE TURNOVER
  • CYTOKINES
  • MONOCYTE CHEMOATTRACTANT PROTEIN (MCP-1)
  • PARATHYROID HORMONE (PTH)

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. / Tamasi, Joseph A.; Vasilov, Anatoliy; Shimizu, Emi; Benton, Noah; Johnson, Joshua; Bitel, Claudine L.; Morrison, Nigel; Partridge, Nicola.

In: Journal of Bone and Mineral Research, Vol. 28, No. 9, 09.2013, p. 1975-1986.

Research output: Contribution to journalArticle

Tamasi, JA, Vasilov, A, Shimizu, E, Benton, N, Johnson, J, Bitel, CL, Morrison, N & Partridge, N 2013, 'Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone', Journal of Bone and Mineral Research, vol. 28, no. 9, pp. 1975-1986. https://doi.org/10.1002/jbmr.1933
Tamasi, Joseph A. ; Vasilov, Anatoliy ; Shimizu, Emi ; Benton, Noah ; Johnson, Joshua ; Bitel, Claudine L. ; Morrison, Nigel ; Partridge, Nicola. / Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone. In: Journal of Bone and Mineral Research. 2013 ; Vol. 28, No. 9. pp. 1975-1986.
@article{5982bbd81c914cd1a9a13f98b35013c9,
title = "Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone",
abstract = "Parathyroid hormone (PTH) has a significant role as an anabolic hormone in bone when administered by intermittent injection. Previous microarray studies in our laboratory have shown that the most highly regulated gene, monocyte chemoattractant protein-1 (MCP-1), is rapidly and transiently induced when hPTH(1-34) is injected intermittently in rats. Through further in vivo studies, we found that rats treated with hPTH(1-34) showed a significant increase in serum MCP-1 levels 2 hours after PTH injection compared with basal levels. Using immunohistochemistry, increased MCP-1 expression in osteoblasts and osteocytes is evident after PTH treatment. PTH also increased the number of marrow macrophages. MCP-1 knockout mice injected daily with hPTH(1-34) showed less trabecular bone mineral density and bone volume compared with wild-type mice as measured by peripheral quantitative computed tomography (pQCT) and micro-computed tomography (μCT). Histomorphometric analysis revealed that the increase in osteoclast surface and osteoclast number observed with intermittent PTH treatment in the wild-type mice was completely eliminated in the MCP-1 null mice, as well as much lower numbers of macrophages. Consequently, the lack of osteoclast and macrophage activity in the MCP-1 null mice was paralleled by a reduction in bone formation. We conclude that osteoblast and osteocyte MCP-1 expression is an important mediator for the anabolic effects of PTH on bone.",
keywords = "BONE ANABOLISM, BONE TURNOVER, CYTOKINES, MONOCYTE CHEMOATTRACTANT PROTEIN (MCP-1), PARATHYROID HORMONE (PTH)",
author = "Tamasi, {Joseph A.} and Anatoliy Vasilov and Emi Shimizu and Noah Benton and Joshua Johnson and Bitel, {Claudine L.} and Nigel Morrison and Nicola Partridge",
year = "2013",
month = "9",
doi = "10.1002/jbmr.1933",
language = "English (US)",
volume = "28",
pages = "1975--1986",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone

AU - Tamasi, Joseph A.

AU - Vasilov, Anatoliy

AU - Shimizu, Emi

AU - Benton, Noah

AU - Johnson, Joshua

AU - Bitel, Claudine L.

AU - Morrison, Nigel

AU - Partridge, Nicola

PY - 2013/9

Y1 - 2013/9

N2 - Parathyroid hormone (PTH) has a significant role as an anabolic hormone in bone when administered by intermittent injection. Previous microarray studies in our laboratory have shown that the most highly regulated gene, monocyte chemoattractant protein-1 (MCP-1), is rapidly and transiently induced when hPTH(1-34) is injected intermittently in rats. Through further in vivo studies, we found that rats treated with hPTH(1-34) showed a significant increase in serum MCP-1 levels 2 hours after PTH injection compared with basal levels. Using immunohistochemistry, increased MCP-1 expression in osteoblasts and osteocytes is evident after PTH treatment. PTH also increased the number of marrow macrophages. MCP-1 knockout mice injected daily with hPTH(1-34) showed less trabecular bone mineral density and bone volume compared with wild-type mice as measured by peripheral quantitative computed tomography (pQCT) and micro-computed tomography (μCT). Histomorphometric analysis revealed that the increase in osteoclast surface and osteoclast number observed with intermittent PTH treatment in the wild-type mice was completely eliminated in the MCP-1 null mice, as well as much lower numbers of macrophages. Consequently, the lack of osteoclast and macrophage activity in the MCP-1 null mice was paralleled by a reduction in bone formation. We conclude that osteoblast and osteocyte MCP-1 expression is an important mediator for the anabolic effects of PTH on bone.

AB - Parathyroid hormone (PTH) has a significant role as an anabolic hormone in bone when administered by intermittent injection. Previous microarray studies in our laboratory have shown that the most highly regulated gene, monocyte chemoattractant protein-1 (MCP-1), is rapidly and transiently induced when hPTH(1-34) is injected intermittently in rats. Through further in vivo studies, we found that rats treated with hPTH(1-34) showed a significant increase in serum MCP-1 levels 2 hours after PTH injection compared with basal levels. Using immunohistochemistry, increased MCP-1 expression in osteoblasts and osteocytes is evident after PTH treatment. PTH also increased the number of marrow macrophages. MCP-1 knockout mice injected daily with hPTH(1-34) showed less trabecular bone mineral density and bone volume compared with wild-type mice as measured by peripheral quantitative computed tomography (pQCT) and micro-computed tomography (μCT). Histomorphometric analysis revealed that the increase in osteoclast surface and osteoclast number observed with intermittent PTH treatment in the wild-type mice was completely eliminated in the MCP-1 null mice, as well as much lower numbers of macrophages. Consequently, the lack of osteoclast and macrophage activity in the MCP-1 null mice was paralleled by a reduction in bone formation. We conclude that osteoblast and osteocyte MCP-1 expression is an important mediator for the anabolic effects of PTH on bone.

KW - BONE ANABOLISM

KW - BONE TURNOVER

KW - CYTOKINES

KW - MONOCYTE CHEMOATTRACTANT PROTEIN (MCP-1)

KW - PARATHYROID HORMONE (PTH)

UR - http://www.scopus.com/inward/record.url?scp=84882617041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882617041&partnerID=8YFLogxK

U2 - 10.1002/jbmr.1933

DO - 10.1002/jbmr.1933

M3 - Article

VL - 28

SP - 1975

EP - 1986

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 9

ER -